Emerging Infectious Diseases (Apr 2022)

In Vitro Confirmation of Artemisinin Resistance in Plasmodium falciparum from Patient Isolates, Southern Rwanda, 2019

  • Welmoed van Loon,
  • Rafael Oliveira,
  • Clara Bergmann,
  • Felix Habarugira,
  • Jules Ndoli,
  • Augustin Sendegeya,
  • Claude Bayingana,
  • Frank P. Mockenhaupt

DOI
https://doi.org/10.3201/eid2804.212269
Journal volume & issue
Vol. 28, no. 4
pp. 852 – 855

Abstract

Read online

Artemisinin resistance in Plasmodium falciparum is conferred by mutations in the kelch 13 (K13) gene. In Rwanda, K13 mutations have increased over the past decade, including mutations associated with delayed parasite clearance. We document artemisinin resistance in P. falciparum patient isolates from Rwanda carrying K13 R561H, A675V, and C469F mutations.

Keywords